Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Construction in Progress (2017 - 2020)

Champions Oncology has reported Construction in Progress over the past 4 years, most recently at $441000.0 for Q4 2020.

  • Quarterly results put Construction in Progress at $441000.0 for Q4 2020, changed N/A from a year ago — trailing twelve months through Oct 2020 was $441000.0 (changed N/A YoY), and the annual figure for FY2020 was $554000.0, up 3362.5%.
  • Construction in Progress for Q4 2020 was $441000.0 at Champions Oncology, up from $114000.0 in the prior quarter.
  • Over the last five years, Construction in Progress for CSBR hit a ceiling of $619000.0 in Q3 2019 and a floor of $15000.0 in Q2 2018.
  • Median Construction in Progress over the past 4 years was $58000.0 (2018), compared with a mean of $196076.9.
  • Biggest five-year swings in Construction in Progress: crashed 96.82% in 2018 and later soared 3362.5% in 2020.
  • Champions Oncology's Construction in Progress stood at $19000.0 in 2017, then surged by 31.58% to $25000.0 in 2018, then soared by 2376.0% to $619000.0 in 2019, then dropped by 28.76% to $441000.0 in 2020.
  • The last three reported values for Construction in Progress were $441000.0 (Q4 2020), $114000.0 (Q3 2020), and $554000.0 (Q2 2020) per Business Quant data.